Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic yogurt versus plain yogurt versus omeprazole for gastroesophageal reflux disease
IRCT20190831044653N4Phase 3Completed
- Sponsor
- North Khorasan University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of omeprazole in gastroesophageal reflux disease (GERD) (3 arms), sponsored by North Khorasan University of Medical Sciences. Primary endpoints: Quality of life and Intensity of reflux. Started Nov 2019; status: completed.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on IRCT20190831044653N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190831044653N4.